This company listing is no longer active
ProMIS Neurosciences Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 1/6
ProMIS Neurosciences has a total shareholder equity of $-6.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $4.4M and $10.6M respectively.
Wichtige Informationen
0%
Verhältnis von Schulden zu Eigenkapital
US$0
Verschuldung
Zinsdeckungsgrad | n/a |
Bargeld | US$3.38m |
Eigenkapital | -US$6.18m |
Gesamtverbindlichkeiten | US$10.61m |
Gesamtvermögen | US$4.43m |
Jüngste Berichte zur Finanzlage
We're A Little Worried About ProMIS Neurosciences' (TSE:PMN) Cash Burn Rate
Oct 11Despite Lacking Profits ProMIS Neurosciences (TSE:PMN) Seems To Be On Top Of Its Debt
Jun 23Is ProMIS Neurosciences (TSE:PMN) A Risky Investment?
Mar 07Is ProMIS Neurosciences (TSE:PMN) A Risky Investment?
Nov 19Recent updates
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: PMN has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Langfristige Verbindlichkeiten: PMN has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: PMN is debt free.
Schulden abbauen: PMN's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilanz
Liquiditätsreserve-Analyse
Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.
Stabile Start- und Landebahn für Bargeld: PMN has less than a year of cash runway based on its current free cash flow.
Vorhersage Cash Runway: PMN has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.7% each year